Glaser, Anna
Butzkueven, Helmut
van der Walt, Anneke
Gray, Orla
Spelman, Tim
Zhu, Chao
Trojano, Maria
Iaffaldano, Pietro
Battaglia, Mario A.
Lucisano, Giuseppe
Vukusic, Sandra
Vukusic, Irena
Casey, Romain
Horakova, Dana
Drahota, Jiri
Magyari, Melinda
Joensen, Hanna
Pontieri, Luigi
Elberling, Frederik
Klyve, Pernilla
Mouresan, Elena Flavia
Forsberg, Lars
Hillert, Jan http://orcid.org/0000-0002-7386-6732
Funding for this research was provided by:
Biogen
Bristol-Myers Squibb
Merck KGaA
Novartis
Roche
Sanofi
Karolinska Institute
Article History
Received: 18 December 2023
Revised: 29 February 2024
Accepted: 5 March 2024
First Online: 1 April 2024
Declarations
:
: Helmut Butzkueven’s Institution has received compensation for advisory boards or lecture fees from Novartis, Biogen, Merck, UCB Pharma and Roche. His institutions receive research funding from Novartis, Biogen, Merck, Roche, The National Health and Medical Research Council of Australia, The Medical Research Future Fund (Australia), Monash Partners, the Trish MS Foundation, The Pennycook Foundation, and MS Australia. He receives personal compensation as the Managing Director of the MSBase Foundation and from the Oxford Health Policy Forum Brain Health Initiative. Anneke van der Walt served on advisory boards for Novartis, Biogen, Merck and Roche and NervGen. She received unrestricted research grants from Novartis, Biogen, Merck and Roche. She is currently a co-Principal investigator on a co-sponsored observational study with Roche, evaluating a Roche-developed smartphone app, Floodlight-MS. She has received speaker’s honoraria and travel support from Novartis, Roche, Biogen and Merck. She serves as the Chief operating Officer of the MSBase Foundation (not-for-profit). Her primary research support is from the National Health and Medical Research Council of Australia and MS Research Australia. Orla Gray has received honoraria as a consultant on scientific advisory boards for Genzyme, Biogen, Merck, Roche and Novartis; has received travel grants from Biogen, Merck, Roche, Sanofi and Novartis; has participated in clinical trials by Biogen, her organisation has received research funding from Biogen. Tim Spelman has received compensation for serving on advisory boards and scientific leadership committees from Biogen. Maria Trojano has served on scientific AB for Biogen, Novartis, Roche, Merck, BMS and Genzyme; has received speaker honoraria from Biogen, Roche, Sanofi, Merck, Genzyme and Novartis. Pietro Iaffaldano has served on scientific advisory boards for Biogen Idec, Bayer, Teva, Roche, Merck Serono, Novartis and Genzyme and has received funding for travel and/or Speaker honoraria from Sanofi Aventis, Genzyme, Biogen Idec, Teva, Merck Serono and Novartis. Sandra Vukusic has received lecturing fees, travel grants and research support from Biogen, BMS-Celgene, Janssen, Merck, Novartis, Roche, Sandoz, Sanofi-Genzyme and Teva. Dana Horakova was supported by the Charles University: Cooperatio Program in Neuroscience, by the project National Institute for Neurological Research (Programme EXCELES, ID Project No. LX22NPO5107)—Funded by the European Union–Next Generation EU, and by General University Hospital in Prague project MH CZ-DRO-VFN64165. She also received compensation for travel, speaker honoraria and consultant fees from Biogen Idec, Novartis, Merck, Bayer, Sanofi Genzyme, Roche, and Teva, as well as support for research activities from Biogen Idec. Melinda Magyari has served in scientific advisory board for Sanofi, Novartis, Merck, and has received honoraria for lecturing from Biogen, Merck, Novartis, Roche, Genzyme, Bristol Myers Squibb. Jan Hillert received honoraria for serving on advisory boards for Biogen, Bristol-Myers-Squibb, Janssen, Merck KGaA, Novartis, Sandoz and Sanofi-Genzyme and speaker’s fees from Biogen, Janssen, Novartis, Merck, Teva, Sandoz and Sanofi-Genzyme. He has served as P.I. for projects sponsored by, or received unrestricted research support from, Biogen, Bristol-Myers-Squibb, Janssen, Merck KGaA, Novartis, Roche, and Sanofi-Genzyme. His MS research is funded by the Swedish Research Council and the Swedish Brain Foundation. Anna Glaser, Chao Zhu, Mario A. Battaglia, Giuseppe Lucisano, Irena Vukusic, Romain Casey, Jiri Drahota, Hanna Joensen, Luigi Pontieri, Frederik Elberling, Pernilla Klyve, Elena Flavia Mouresan, Lars Forsberg declare no conflict of interest.